glp-1 weight loss comparison Lilly orforglipron oral phase 3 trial GLP-1 Agonists for Weight Loss:

MTC is a rare cancer of the parafollicular cells, or C-cells, in the thyroid, with around 1,000 new cases diagnosed in the United States each year ( The pathway mechanisms that underpin GLP-1R agonism-induced C-cell hyperplasia are not well understood, however some have connected GLP-1 RA-related C-cell effects with mTOR activation ( MTC has a poor prognosis, and while representing less than 5% of thyroid carcinomas, it is responsible for 13% of thyroid carcinoma deaths ( Materials and methods Data acquisition and analysis Transcriptome Profiles for all 33 human cancers in The Cancer Genome Atlas (TCGA) were acquired from the Genomic Data Commons (GDC) and analyzed in R (V.4.4.1)

Zietek, T., & Rath, E

Largent, E

Factors associated with maintenance of an improved ejection fraction: an echocardiogram-based registry study

Menopause is a coordinated disruption, one that withdraws hormonal signals that had been quietly governing cellular energy regulation, inflammatory tone, mitochondrial function, and tissue maintenance across virtually every system in the body simultaneously

Their oral bacterial ecology already favors cavity-producing organisms, and reduced saliva removes one of the few remaining protective barriers